Cryo-Cell International Inc (CCEL)
XASE:CCEL
CCEL Stock Chart & Stats
$4.09
-$0.37(-4.74%)
At close: 4:00 PM EST
$4.09
-$0.37(-4.74%)
Day’s Range― - ―
52-Week Range$2.72 - $6.35
Previous CloseN/A
Volume3.40K
Average Volume (3M)4.07K
Market Cap
$27.95M
Enterprise Value$30.84M
Total Cash (Recent Filing)$3.30M
Total Debt (Recent Filing)$3.20M
Price to Earnings (P/E)―
Beta0.10
Next Earnings
Apr 22, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield11.14%
Share Statistics
EPS (TTM)-0.46
Shares Outstanding8,055,150
10 Day Avg. Volume4,683
30 Day Avg. Volume4,066
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-1.73
Price to Sales (P/S)1.02
P/FCF Ratio6.12
Enterprise Value/Market Cap1.10
Enterprise Value/Revenue0.98
Enterprise Value/Gross Profit1.27
Enterprise Value/Ebitda64.17
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)-0.42
Revenue Forecast (FY)$29.90M
Bulls Say, Bears Say
Bulls Say
Analyst EstimatesAnalysts raised future financial estimates, which signals an improving consensus outlook for revenue and profitability.
EarningsQuarterly results exceeded analyst expectations, indicating stronger operating performance that can support upward revisions to valuation models.
Recurring Revenue And Cash Flow VisibilityGrowing deferred revenue and recurring contracts increase visibility into future cash flows and support the company's ability to fund operations with available credit.
Bears Say
Legal And Arbitration RiskUnresolved arbitration with a key partner creates significant uncertainty around strategic relationships and could disrupt revenue recognition or partnership agreements.
Profitability RiskAn inventory impairment combined with higher litigation-related expenses reduced reported earnings and may pressure future profitability and cash reserves.
Revenue Growth PressureFewer new specimens being processed is reducing revenue growth and raises concerns about demand trends and market penetration.
Cryo-Cell International News
CCEL FAQ
What was Cryo-Cell International Inc’s price range in the past 12 months?
Cryo-Cell International Inc lowest stock price was $2.72 and its highest was $6.35 in the past 12 months.
What is Cryo-Cell International Inc’s market cap?
Cryo-Cell International Inc’s market cap is $27.95M.
When is Cryo-Cell International Inc’s upcoming earnings report date?
Cryo-Cell International Inc’s upcoming earnings report date is Apr 22, 2026 which is in 9 days.
How were Cryo-Cell International Inc’s earnings last quarter?
Cryo-Cell International Inc released its earnings results on Feb 27, 2026. The company reported -$0.46 earnings per share for the quarter, missing the consensus estimate of -$0.09 by -$0.37.
Is Cryo-Cell International Inc overvalued?
According to Wall Street analysts Cryo-Cell International Inc’s price is currently Overvalued.
Does Cryo-Cell International Inc pay dividends?
Cryo-Cell International Inc pays a Quarterly dividend of $0.15 which represents an annual dividend yield of 11.14%. See more information on Cryo-Cell International Inc dividends here
What is Cryo-Cell International Inc’s EPS estimate?
Cryo-Cell International Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cryo-Cell International Inc have?
Cryo-Cell International Inc has 8,055,150 shares outstanding.
What happened to Cryo-Cell International Inc’s price movement after its last earnings report?
Cryo-Cell International Inc reported an EPS of -$0.46 in its last earnings report, missing expectations of -$0.09. Following the earnings report the stock price went down -3.529%.
Which hedge fund is a major shareholder of Cryo-Cell International Inc?
Currently, no hedge funds are holding shares in CCEL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cryo-Cell International Inc
Cryo-Cell International (CCEL) is a leading biotechnology company specializing in the collection, processing, and storage of stem cells derived from umbilical cord blood and tissue. Founded in 1992, CCEL operates primarily in the regenerative medicine sector, offering services that cater to families looking to preserve their newborn's stem cells for potential future medical use. The company's core offerings include private and public cord blood banking, as well as tissue banking services, which are critical for various therapeutic applications and research.
CCEL Stock 12 Month Forecast
Average Price Target
―Technical Analysis
American Shared Hospital Services
―
Concord Medical Services
―
―
DocGo
―
P3 Health Partners
―
Ownership Overview
35.70% Insiders
2.15% Mutual Funds
7.14% Other Institutional Investors
53.27% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---